« Back
Home /
TNF-Related Apoptosis-Inducing Ligand (TRAIL)

TNF-Related Apoptosis-Inducing Ligand (TRAIL)

€4,545.00

Excl. VAT

Item no.	THP-0267
Manufacturer	Creative BioMart
Amount	1ea
Category	Metabolism Diabetes Peptides & Proteins Recombinant Proteins Cell Biology Obesity Cell Status Necrosis Apoptosis Cardiovascular Research Ischemia & Reperfusion Injury
Type	Proteins
Specific against	Hu
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Available
Description	TRAIL/APO 2 Ligand Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 168 amino acids (Met+Arg115-Gly281) and having a molecular mass of ca.21kDa. The sTRAIL is purified by proprietary chromatographic techniques.
Sequences	MRERGPQRVA AHITGTRGRS NTLSSPNSKN EKALGRKINS WESSRSGHSF LSNLHLRNGE LVIHEKGFYY IYSQTYFRFQ EEIKENTKND KQMVQYIYKY TSYPDPILLM KSARNSCWSK DAEYGLYSIY QGGIFELKEN DRIFVSVTNE HLIDMDHEAS FFGAFLVG.
Molecular Weight	21 kDa
Synonyms	Tumor necrosis factor ligand superfamily member 10; TNF-related apoptosis-inducing ligand; Protein TRAIL; Apo-2 ligand; Apo-2L; CD253 antigen; TL2; APO2L; TNFSF10;
Applications info	The process of apoptosis is caspase-8-dependent. This protein preferentially induces apoptosis in transformed and tumor cells, but does not appear to kill normal cells.
Examples of Clinical Use	Inducing apoptosis in transformed and tumor cells
Affected organisms	Humans
Source	E. coli

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1ea

Listprice: €4,545.00

Price: €4,545.00

available

Delivery expected until 10/2/2025

Quantity:

Compare